The Therapy of Cardiogenic Shock
Authors: ALBERT J. MILLER
Journal: Annals of Internal Medicine (1963)

Editorials1 May 1963The Therapy of Cardiogenic ShockALBERT J. MILLER, M.D., F.A.C.P., BENJAMIN M. KAPLAN, M.D.ALBERT J. MILLER, M.D., F.A.C.P., BENJAMIN M. KAPLAN, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-58-5-901 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptPrimary failure of the heart to maintain an adequate output, as may be seen after acute myocardial infarction, can result in the clinical syndrome of "cardiogenic shock." Though cardiogenic shock differs from hypovolemic and the other types of shock, it may be clinically indistinguishable from them. Irrespective of initiating mechanisms, the presenting symptoms and signs of shock are mainly due to a decrease in circulating blood volume and bodily peripheral compensatory reactions. Appropriate therapy requires an appreciation of the initiating factors, the stage of progression of the shock, and the factors operating to maintain the state of shock.The treatment...References1. MILLERKAPLAN AJBM: Vasopressor therapy in cardiogenic shock and hypotension. Amer. Pract. 12: 755, 1961. Google Scholar2. BINDER MJ: The mechanism and treatment of shock in acute myocardial infarction. Prog. Cardiov. Dis. 1: 206, 1958. CrossrefMedlineGoogle Scholar3. MILLERMOSER AJEA: Arterenol therapy for shock after acute myocardial infarction and pulmonary embolization. JAMA 169: 2000, 1959. CrossrefMedlineGoogle Scholar4. BIORCK G: Comments in discussion of myocardial shock, in Shock, Pathogenesis and Therapy, Ciba International Symposium, ed. by Bock, K. D., Springer-Verlag, Berlin, 1962, pp. 267-268. Google Scholar5. REMINGTONHAMILTONBOYDHAMILTONCADDELL JWWFGHWFHM: Role of vasoconstriction in the response of the dog to hemorrhage. Amer. J. Physiol. 161: 116, 1950. CrossrefMedlineGoogle Scholar6. LONGERBEAMLILLEHEISCOTTROSENBERG JKRCWRJC: Visceral factors in shock. JAMA 181: 878, 1962. CrossrefMedlineGoogle Scholar7. NICKERSON M: Drug therapy of shock, in Shock, Pathogenesis and Therapy, Ciba International Symposium, ed. by Bock, K. D., Springer-Verlag, Berlin, 1962, pp. 356-368. Google Scholar8. FRIEDBERG CK: Cardiogenic shock in acute myocardial infarction. Circulation 23: 325, 1961. CrossrefMedlineGoogle Scholar9. KATZ LN: Analysis of the several factors regulating the performance of the heart. Physiol. Rev. 35: 90, 1955. CrossrefMedlineGoogle Scholar10. KATZGOKSELFEINBERGBOYD LNFHE: Does coronary flow determine myocardial oxygen consumption? Circulation 26: 741, 1962. Google Scholar11. ROSEKOTCOHNFREISECKERT JCPAJNEDGE: Comparison of the effects of angiotensin and norepinephrine on the pulmonary circulation, systemic arteries and veins, and systemic vascular capacity of the dog. Circulation 25: 247, 1962. CrossrefMedlineGoogle Scholar12. FINNERTY FA: Hemodynamics of angiotensin in man. Ibid.: 255. Google Scholar13. HIRSCHMILLERKATZ LAJLN: The effects of norepinephrine and angiotensin II on myocardial function in the dog. Unpublished observations. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: ALBERT J. MILLER, M.D., F.A.C.P.; BENJAMIN M. KAPLAN, M.D.Affiliations: Cardiovascular Institute Michael Reese Hospital and Medical Center Chicago, Illinois PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPhysiologie und Pathologie des Renin/Angiotensin-SystemsPharmacological basis for the use of adrenergic agonists and antagonists in cardiogenic shock and hypotensionCardiovascular Effects of Sustained Norepinephrine Infusions. I. HemodynamicsThe effects of angiotensin on the circulation and myocardial metabolism of dogs with experimentally produced myocardial infarctionEFFECT OF DRUGS ON INDUCED VENTRICULAR FIBRILLATIONCYTOTOXIC DRUGS IN BRONCHIAL CARCINOMAAngiotensin II in the treatment of shock following myocardial infarctionSuccessful Therapy of Prolonged Hypotension with an Adrenergic Beta-Receptor Blocking Agent 1 May 1963Volume 58, Issue 5Page: 901-902KeywordsAcute myocardial infarctionBlood volumeHeart failureShockSigns and symptoms ePublished: 1 December 2008 Issue Published: 1 May 1963 PDF downloadLoading ...